Resapp Health Ltd
ASX:RAP
P/OCF
Price to OCF
Price to Operating Cash Flow (P/OCF) ratio is a valuation multiple that measures the value of a company’s market capitalization relative to the operating cash flow it generates. Some analysts prefer P/OCF over P/E since earnings can be more easily manipulated than cash flows.
Market Cap | P/OCF | ||||
---|---|---|---|---|---|
AU |
Resapp Health Ltd
ASX:RAP
|
176.2m AUD | -43.9 | ||
US |
Veeva Systems Inc
NYSE:VEEV
|
32.4B USD | 35.6 | ||
US |
Cerner Corp
NASDAQ:CERN
|
27.9B USD | 16.4 | ||
US |
Change Healthcare Inc
NASDAQ:CHNG
|
9B USD | 13.4 | ||
JP |
M3 Inc
TSE:2413
|
1.3T JPY | 21.5 | ||
AU |
Pro Medicus Ltd
ASX:PME
|
11.4B AUD | 160 | ||
US |
Inspire Medical Systems Inc
NYSE:INSP
|
7B USD | 284.7 | ||
US |
Doximity Inc
NYSE:DOCS
|
4.4B USD | 26.6 | ||
SE |
Sectra AB
STO:SECT B
|
42.7B SEK | 74.3 | ||
US |
Evolent Health Inc
NYSE:EVH
|
3.1B USD | 22.1 | ||
US |
Goodrx Holdings Inc
NASDAQ:GDRX
|
2.8B USD | 20.5 |
P/OCF Forward Multiples
Forward P/OCF multiple is a version of the P/OCF ratio that uses forecasted operating cash flow for the P/OCF calculation. 1-Year, 2-Years, and 3-Years forwards use operating cash flow forecasts for 1, 2, and 3 years ahead, respectively.